Assessing the Potential of N-Butyl-l-deoxynojirimycin (l-NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent.
Esposito A, Rossi A, Stabile M, Pinto G, De Fino I, Melessike M, Tamanini A, Cabrini G, Lippi G, Aureli M, Loberto N, Renda M, Galietta LJV, Amoresano A, Dechecchi MC, De Gregorio E, Bragonzi A, Guaragna A.
Esposito A, et al. Among authors: amoresano a.
ACS Pharmacol Transl Sci. 2024 May 10;7(6):1807-1822. doi: 10.1021/acsptsci.4c00044. eCollection 2024 Jun 14.
ACS Pharmacol Transl Sci. 2024.
PMID: 38898954